Case studies

See how your peers from The University of Edinburgh have started companies grounded in their areas of research, and what support they’ve benefitted from along the way.

After a first degree in physics and a PhD in optical techniques, Dr Alex McVey joined Prof Teuta Pilizota’s lab, where they quickly discovered the pain of manually culturing bacteria.

Billions of people around the world are bilingual, yet bilingualism remains largely misunderstood and much of the existing research is inaccessible.

Macomics is a spinout company from the Centre for Reproductive Health at the University of Edinburgh, developing novel therapeutics to modulate the activity of macrophages, increasing the body’s immune defence against tumours in cancer sufferers.

A team behind new thermal energy storage technology that could help replace fossil fuels has been awarded £3.6 million by the Department for Energy Security and Net Zero for a trial at a whisky distillery in Scotland.

A collaborative research project between world-leading researchers in healthcare and computer sciences at the University of Edinburgh has led to the launch of spinout company SpeakUnique, which provides a state-of-the-art synthetic voice personalisation service for communication aid users.

With support from Edinburgh Innovations, Pheno, a spin out from the University of Edinburgh has combined world-class clinical and drug discovery expertise, and is uniquely positioned to provide novel treatments that could halt the progression and alleviate the debilitating symptoms of multiple sclerosis (MS).

Dr Patras and his team were able to turn their novel technology into a commercial proposition through support from Edinburgh Innovations Enterprise team.

Earth Blox is a cloud-based software-as-a-service provider that empowers anyone, anywhere to create their own Earth observation and satellite data solutions.

When specialist healthcare investment company Syncona Ltd discovered the ground-breaking cell therapy research being conducted by scientists at the University of Edinburgh it sparked a collaboration that went on to fuel the launch of pioneering biotechnology spinout Resolution Therapeutics.